General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Sanofi-Aventis(SIGNIFICANT), Amgen Inc.(SIGNIFICANT), Afimmune(MODEST), Boehringer Ingelheim Pharmaceuticals, Inc(SIGNIFICANT), Eli Lilly and Company(SIGNIFICANT), Hanmi Pharmaceuticals(MODEST), Merck Sharp & Dohme(MODEST), Novo Nordisk Inc.(SIGNIFICANT), AstraZeneca Pharmaceuticals(MODEST), Pfizer Inc(SIGNIFICANT), Novartis Corporation(MODEST), Abbott Laboratories(MODEST), Janssen Pharmaceuticals, Inc(MODEST) RESEARCH/RESEARCH GRANTS: AstraZeneca Pharmaceuticals(SIGNIFICANT), Boehringer Ingelheim Pharmaceuticals, Inc(SIGNIFICANT), Novartis Corporation(MODEST), Roche Diagnostics(SIGNIFICANT)

View Full Disclosure